These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2867036)

  • 21. [Ocular complications in chronic psychiatric patients caused by prolonged use of antipsychotic drugs (author's transl)].
    Yang Y
    Zhonghua Yan Ke Za Zhi; 1979; 15(3):198-200. PubMed ID: 45367
    [No Abstract]   [Full Text] [Related]  

  • 22. [Complications involving the eye caused by psychotrophic drugs].
    Gol'dovskaia IL
    Vestn Oftalmol; 1970; 6():54-7. PubMed ID: 5510856
    [No Abstract]   [Full Text] [Related]  

  • 23. Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.
    Lal S; Bloom D; Silver B; Desjardins B; Krishnan B; Thavundayil J; Thompson T
    J Psychiatry Neurosci; 1993 Jul; 18(4):173-7. PubMed ID: 8104031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ocular changes occurring with prolonged high dose chlorpromazine therapy. Results from a collaborative study.
    Prien RF; DeLong SL; Cole JO; Levine J
    Arch Gen Psychiatry; 1970 Nov; 23(5):464-8. PubMed ID: 5478574
    [No Abstract]   [Full Text] [Related]  

  • 25. Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective study.
    Sramek JJ; Simpson GM; Morrison RL; Heiser JF
    J Clin Psychiatry; 1986 Jun; 47(6):305-9. PubMed ID: 2872206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Letter: Side effects of chlorpromazine and piperacetazine.
    Ananth J; Kulkarni AS
    Am J Psychiatry; 1974 Jun; 131(6):722. PubMed ID: 4151260
    [No Abstract]   [Full Text] [Related]  

  • 27. Intraoperative floppy-iris syndrome associated with chronic use of chlorpromazine.
    Unal M; Yücel I; Tenlik A
    Eye (Lond); 2007 Sep; 21(9):1241-2. PubMed ID: 17603467
    [No Abstract]   [Full Text] [Related]  

  • 28. Ocular adverse effects of neuropsychiatric agents. Incidence and management.
    Oshika T
    Drug Saf; 1995 Apr; 12(4):256-63. PubMed ID: 7646824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors related to prescription dosage in Japanese psychiatric hospitals.
    Nawata S; Yamauchi K; Ikegami N
    Psychiatry Clin Neurosci; 2005 Feb; 59(1):70-6. PubMed ID: 15679543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ocular melanosis with special reference to chlorpromazine.
    Cameron ME
    Br J Ophthalmol; 1967 May; 51(5):295-305. PubMed ID: 6022771
    [No Abstract]   [Full Text] [Related]  

  • 31. Neuroleptic drug-induced changes in platelet levels.
    Holt RJ
    J Clin Psychopharmacol; 1984 Jun; 4(3):130-2. PubMed ID: 6145727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical factors related to gains in body mass index (BMI) among patients under long-term antipsychotic treatment].
    Koga M
    Seishin Shinkeigaku Zasshi; 2003; 105(4):473-88. PubMed ID: 12806910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cognition disorders in the course of treatment with neuroleptics].
    Puzyński S; Jakubik A; Kalinowski A
    Psychiatr Pol; 1973; 7(4):453-9. PubMed ID: 4149519
    [No Abstract]   [Full Text] [Related]  

  • 34. Antipsychotic-withdrawal akathisia versus antipsychotic-induced akathisia: further evidence for the existence of tardive akathisia.
    Dufresne RL; Wagner RL
    J Clin Psychiatry; 1988 Nov; 49(11):435-8. PubMed ID: 2903141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chlorpromazine ocular toxicity.
    Johnson AW
    N C Med J; 1967 Nov; 28(11):474-6. PubMed ID: 5235902
    [No Abstract]   [Full Text] [Related]  

  • 36. Incidence and significance of chlorpromazine-induced eye changes.
    De Long SL
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:19-22. PubMed ID: 4876741
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical studies on eye changes during long-term chloroquine therapy].
    Pambor R
    Dtsch Gesundheitsw; 1968 Dec; 23(50):2383-9. PubMed ID: 5729806
    [No Abstract]   [Full Text] [Related]  

  • 38. Ocular complications of phenothiazines.
    Mathalone MB
    Trans Ophthalmol Soc U K (1962); 1966; 86():77-88. PubMed ID: 5226613
    [No Abstract]   [Full Text] [Related]  

  • 39. [Ocular and cutaneous changes in patients exposed to prolonged treatment with neuroleptic drugs].
    Francesconi G; Di Tizio A; Cameo D
    Ann Ottalmol Clin Ocul; 1968 Jul; 94(7):835-52. PubMed ID: 4236709
    [No Abstract]   [Full Text] [Related]  

  • 40. Chlorpromazine-associated antiphospholipid antibody syndrome.
    Iyer HV; Moudgil H; Newman P; Srinivasan KS
    Ann Pharmacother; 2007 Mar; 41(3):528. PubMed ID: 17341541
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.